3-hydroxybutyric acid has been researched along with insulin, isophane in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dahl-Jørgensen, K; Haakens, K; Hanssen, KF; Torjesen, P; Try, K; Vaaler, S | 1 |
| Bolli, G; Brunetti, P; Del Sindaco, P; Di Vincenzo, A; Epifano, L; Kassi, G; Lalli, C; Modarelli, F; Pampanelli, S; Perriello, G; Rambotti, AM; Torlone, E | 1 |
| Ahmed, AB; Home, PD; Mallias, J | 1 |
| Hofmann, U; Jung, R; Rosak, C | 1 |
2 trial(s) available for 3-hydroxybutyric acid and insulin, isophane
| Article | Year |
|---|---|
Optimization of evening insulin dose in patients using the short-acting insulin analog lispro.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Circadian Rhythm; Cross-Over Studies; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hydroxybutyrates; Hypoglycemic Agents; Insulin; Insulin Lispro; Insulin, Isophane; Male; Middle Aged; Postprandial Period | 1998 |
Insulin glargine maintains equivalent glycemic control and better lipometabolic control than NPH insulin in type 1 diabetes patients who missed a meal.
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Diabetes Mellitus, Type 1; Eating; Fatty Acids, Nonesterified; Female; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Lipid Metabolism; Male | 2008 |
2 other study(ies) available for 3-hydroxybutyric acid and insulin, isophane
| Article | Year |
|---|---|
Early morning glycaemia and the metabolic consequences of delaying breakfast/morning insulin. A comparison of continuous subcutaneous insulin infusion and multiple injection therapy with human isophane or human ultralente insulin at bedtime in insulin-dep
Topics: 3-Hydroxybutyric Acid; Adult; Blood Glucose; Circadian Rhythm; Diabetes Mellitus, Type 1; Humans; Hydroxybutyrates; Infusion Pumps, Implantable; Injections, Subcutaneous; Insulin; Insulin Infusion Systems; Insulin, Isophane; Insulin, Long-Acting | 1989 |
Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.
Topics: 3-Hydroxybutyric Acid; Adult; Alanine; Analysis of Variance; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; Fatty Acids, Nonesterified; Female; Glucagon; Glycerol; Humans; Hydroxybutyrates; Infusions, Intravenous; Insulin; Insulin Lispro; Insulin, Isophane; Lactates; Male; Postprandial Period; Recombinant Proteins | 1996 |